Compare HURN & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HURN | LMAT |
|---|---|---|
| Founded | 2002 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 1.9B |
| IPO Year | 2004 | 2006 |
| Metric | HURN | LMAT |
|---|---|---|
| Price | $179.75 | $83.90 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $190.25 | $101.83 |
| AVG Volume (30 Days) | 131.3K | ★ 182.6K |
| Earning Date | 10-28-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 0.96% |
| EPS Growth | ★ 32.32 | 27.40 |
| EPS | ★ 5.98 | 2.32 |
| Revenue | ★ $1,618,977,000.00 | $240,866,000.00 |
| Revenue This Year | $14.19 | $15.17 |
| Revenue Next Year | $9.49 | $9.07 |
| P/E Ratio | ★ $30.01 | $36.08 |
| Revenue Growth | 12.67 | ★ 13.07 |
| 52 Week Low | $118.25 | $71.42 |
| 52 Week High | $180.29 | $105.55 |
| Indicator | HURN | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 76.92 | 42.77 |
| Support Level | $168.79 | $82.31 |
| Resistance Level | $166.87 | $84.86 |
| Average True Range (ATR) | 4.66 | 2.72 |
| MACD | 1.02 | -0.01 |
| Stochastic Oscillator | 97.67 | 23.64 |
Huron Consulting Group Inc is a professional services firm. The company provides expertise in technology, operations, advisory services, & analytics through three operating segments namely Healthcare, Education, and Commercial. Healthcare segment helps the firms to transform and innovate the delivery model to focus on patient wellness by improving quality outcomes, minimizing care variation and fundamentally improving patient and population health, Education segment provides management consulting and technology solutions, and Commercial segment is focused on serving industries and organizations facing disruption and regulatory change. It generates a majority of its revenue from the Healthcare Segment.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.